These results suggest that non-toxic concentrations of COE ranging from 5 to 20 μg/ml could inhibit RA-FLSs migration and invasion induced by IL-1β and TNF-α in vitro, indicating COE might provide benefit in the treatment of RA by inhibiting inflammation-induced FLSs invasion. Here, TNF is linked to rheumatoid arthritis.